Cited by 110Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentHormonal and reproductive studies

The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.

Familial factors affecting prostatic cancer risk and plasma sex-steroid levels

Wayne Meikle, A., Smith, Joseph A., West, Dee W.·1985·The Prostate

DOI 10.1002/pros.2990060202

Open this paper in CoChat — free account

Abstract

Whether familial factors affect the frequency of prostatic cancer and the plasma content of sex‐steroids was investigated. Brothers (n = 257) of probands (n = 150) diagnosed with prostatic cancer before age 62 years had a fourfold higher risk for developing the disease than men in the general population in the State of Utah and their brothers‐in‐law (n = 202). Familial factors markedly affected the plasma content of sex steroids (testosterone, dihydro‐testosterone, the ratio of testosterone to DHT, sex‐hormone binding globulin, and the free fraction of testosterone) in nonendocrinologically treated probands and their brothers and sons and in normal men in the general populations. Index cases and their brothers and sons had a significantly lower mean plasma testosterone content than controls of comparable age. Preliminary data suggest that the metabolic clearance rate of testosterone and the conversion ratio of testosterone to estradiol are relatively high in probands. The observations indicate that familial factors are potent risk factors for the development of prostatic cancer. They also suggest that plasma androgen values in families with prostatic cancer cluster in the lower range of normal and that plasma sex‐steroid content is more similar in each brothers with or without prostatic cancer than among nonbrothers.

Integrity signals

Registry

Crossref · 10.1002/pros.2990060202

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical Methods in Medical Research.
Wickham, C. A. C., Armitage, P., & Berry, G. (1988) · Journal of the Royal Statistical Society Series A (Statistics in Society) · doi:10.2307/2982765 · Cited by 1,410
Testosterone Secretion and Metabolism in Male Senescence
Vermeulen, A., Rubens, R. D., & Verdonck, L. (1972) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-34-4-730 · Cited by 536
Increased Estrogen Production in Obese Men*
SCHNEIDER, G. T., Kirschner, M. A., Berkowitz, R. D., & Ertel, N. H. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-4-633 · Cited by 507
The Testis in Normal and Infertile Men.
(1977) · Annals of Internal Medicine · doi:10.7326/0003-4819-87-6-805_4 · Cited by 483
Low serum testosterone and sex-hormone-binding-globulin in massively obese men
GLASS, A. R., SWERDLOFF, R. S., BRAY, G. A., DAHMS, W. T., & ATKINSON, R. L. (1977) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-45-6-1211 · Cited by 430
Androstenedione production and interconversion rates measured in peripheral blood and studies on the possible site of its conversion to testosterone
Horton, R., & Tait, J. F. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105344 · Cited by 401
Capacity of the Testosterone-Binding Globulin in Human Plasma and Influence of Specific Binding of Testosterone on Its Metabolic Clearance Rate
Vermeulen, A., Verdonck, L., Straeten, M. V. D., & ORIE, N. (1969) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-29-11-1470 · Cited by 385
Conversion of blood androgens to estrogens in normal adult men and women
Longcope, C., Kato, T., & Horton, R. (1969) · Journal of Clinical Investigation · doi:10.1172/jci106185 · Cited by 368
Effect of Alcohol (Ethanol) Administration on Sex-Hormone Metabolism in Normal Men
Gordon, G. G., Altman, K. I., Southren, A. L., Rubin, E., & Lieber, C. S. (1976) · New England Journal of Medicine · doi:10.1056/nejm197610072951501 · Cited by 364
CHANGES IN THE PITUITARY‐TESTICULAR SYSTEM WITH AGE
Baker, H. W. G., Burger, H., KRETSER, D. M. D., Hudson, B., O'connor, S., Wang, C.-L., MIROVICS, A., Court, J. M., Dunlop, M., & RENNIE, G. C. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb01964.x · Cited by 305

Flagged first, then by citations

Show all 49 references

1 of the 49 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

Moore RA, 1944, Benign hypertrophy and a carcinoma of the prostate. Occurrence and experimental production in animals, Surgery, 16, 152
Silverberg E, 1977, Cancer statistics, Cancer, 27, 26
Cannon L, 1982, Genetic epidemiology of prostate cancer in the Utah Mormon Genealogy, Cancer Surv, 1, 47
Lipsett MB, 1977, The Human Testis, 407
Heyns W, 1977, The steroid‐binding β‐globulin of human plasma, Adv Steroid Biochem Pharmacol, 6, 59

Sorted by citations

Mendelian inheritance of familial prostate cancer.
Carter, B. S., Beaty, T. H., Steinberg, G. D., Childs, B., & Walsh, P. C. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3367 · Cited by 780
Family history and the risk of prostate cancer
Steinberg, G. D., Carter, B. S., Beaty, T. H., Childs, B., & Walsh, P. C. (1990) · The Prostate · doi:10.1002/pros.2990170409 · Cited by 718
Human prostate cancer risk factors
Bostwick, D. G., BURKE, H. B., Djakiew, D., Euling, S. Y., Ho, S., Landolph, J. R., MORRISON, H. I., Sonawane, B. R., Shifflett, T., Waters, D. J., et al. (2004) · Cancer · doi:10.1002/cncr.20408 · Cited by 675
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
Predisposing Gene for Early-Onset Prostate Cancer, Localized on Chromosome 1q42.2-43
Berthon, P., Valéri, A., Cohen-Akenine, A., Drelon, E., Paiss, T., Wöhr, G., Latil, A., Millasseau, P., Mellah, I., Cohen, N., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301879 · Cited by 361
A systematic review and meta‐analysis of familial prostate cancer risk
Johns, L. E., & Houlston, R. S. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04232.x · Cited by 312
Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis
Bosland, M. C. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024244 · Cited by 309
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma
Zeegers, M. P., Jellema, A., & D, H. O. M. (2003) · Cancer · doi:10.1002/cncr.11262 · Cited by 224
Molecular Genetics and Epidemiology of Prostate Carcinoma
Ruijter, E., van de Kaa, C., Miller, G. J., Ruiter, D. J., Debruyne, F. M. J., & Schalken, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.1.0356 · Cited by 183
INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS
MILLER, L. R., Partin, A. W., Chan, D. W., Bruzek, D. J., Dobs, A. S., Epstein, J. I., & Walsh, P. C. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62922-7 · Cited by 178
A Genome Screen of Multiplex Sibships with Prostate Cancer
Suarez, B. K., Lin, J., Burmester, J. K., Broman, K. W., Weber, J. L., Banerjee, T. K., Goddard, K. A. B., Witte, J. S., Elston, R. C., & Catàlona, W. J. (2000) · The American Journal of Human Genetics · doi:10.1086/302818 · Cited by 156
Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns
Sastre‐Garau, X., Jouve, M., Asselain, B. J. R., Vincent‐Salomon, A., Beuzeboc, P., Dorval, T., Durand, J. C., Fourquet, A., & Pouillart, P. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960101)77:1 · Cited by 422
Family History and Prostate Cancer Risk
Lesko, S. M., Rosenberg, L. A., & Shapiro, S. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008876 · Cited by 147
Role of Androgens in Prostatic Cancer
Isaacs, J. T. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61152-8 · Cited by 150
Epidemiologic evidence regarding predisposing factors to prostate cancer
Carter, B. S., Carter, H. B., & Isaacs, J. T. (1990) · The Prostate · doi:10.1002/pros.2990160302 · Cited by 145
Family history and prostate cancer risk in a population-based cohort of Iowa men.
Cerhan, J. R., Parker, A. S., Putnam, S. D., Chiu, B. C. ‐., Lynch, C. F., Cohen, M. B., Torner, J. C., & Cantor, K. P. (1999) · PubMed · Cited by 124
Sex hormone-induced prostatic carcinogenesis in the Noble rat: The role of insulin-like growth factor-1 (IGF-1) and vascular endothelial growth factor (VEGF) in the development of prostate cancer
Wang, Y. Z., & Wong, Y. C. (1998) · The Prostate · doi:10.1002/(sici)1097-0045(19980515)35:3 · Cited by 123
Genetics and the common cancers.
Peto, J., & Houlston, R. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00255-6 · Cited by 127
Original Articles
Bastacky, S., Wojno, K. J., Walsh, P. C., Carmichael, M. J., & Epstein, J. I. (1995) · The Journal of Urology · doi:10.1097/00005392-199503001-00023 · Cited by 119
Original Articles: Prostate Cancer: Pathological Features of Hereditary Prostate Cancer
Bastacky, S., Wojno, K. J., Walsh, P. C., Carmichael, M. J., & Epstein, J. I. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67619-5 · Cited by 117
Vitamin D and Prostate Cancer
Feldman, D., Skowroński, R., & Peehl, D. M. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-0949-7_5 · Cited by 110
Gene therapy for human prostate cancer. Translational research in the hormone refractory dunning prostate cancer model
Carducci, M. A., Ayyagari, S. R., Sanda, M. G., & Simons, J. W. (1995) · Cancer · doi:10.1002/1097-0142(19950401)75:7+ · Cited by 14
Epidemiology of Prostate Cancer
Meikle, A. W., & Smith, J. A. J. (1990) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01366-5 · Cited by 108
Self-citation
Serum Androgens: Associations With Prostate Cancer Risk and Hair Patterning
Demark‐Wahnefried, W., Lesko, S. M., Conaway, M. R., Robertson, C. N., Clark, R. V., Lobaugh, B., Mathias, B. J., Strigo, T. S., & Paulson, D. F. (1997) · Journal of Andrology · doi:10.1002/j.1939-4640.1997.tb01964.x · Cited by 107
Incidence of cancer of the esophagus in the US by histologic type
Yang, P. C.-P., & Davis, S. (1988) · Cancer · doi:10.1002/1097-0142(19880201)61:3 · Cited by 188
Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials
Trost, L. W., & Mulhall, J. P. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.068 · Cited by 98
Family History and Risk of Fatal Prostate Cancer
Rodríguez, C., Calle, E. E., Miracle-McMahill, H. L., Tatham, L. M., Wingo, P. A., Thun, M. J., & Heath, C. W. (1997) · Epidemiology · doi:10.1097/00001648-199710000-00007 · Cited by 97
Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancer
Montie, J. E., & Pienta, K. J. (1994) · Urology · doi:10.1016/0090-4295(94)90163-5 · Cited by 94
Serum androgens and prostate cancer.
Nomura, A. M. Y., Stemmermann, G. N., Chyou, P.-H., Henderson, B. E., & Stanczyk, F. Z. (1996) · PubMed · Cited by 91
BIOLOGICAL AGGRESSIVENESS OF HEREDITARY PROSTATE CANCER: LONG-TERM EVALUATION FOLLOWING RADICAL PROSTATECTOMY
Bova, G. S., Partin, A. W., Isaacs, S. D., Carter, B. S., BEATY, T. L., Isaacs, W. B., & Walsh, P. C. (1998) · The Journal of Urology · doi:10.1016/s0022-5347(01)62748-4 · Cited by 86
Hypermethylation of the APC (adenomatous Polyposis Coli) gene promoter region in human colorectal carcinoma
Hiltunen, M., Alhonen, L. I., Koıstınaho, J., Myöhänen, S., Pääkkönen, M. E., Marin, S., Kosma, V.-M., & Jänne, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970317)70:6 · Cited by 192
Familial Aspects of Prostate Cancer: A Case Control Study
Keetch, D. W., Rice, J. P., Suarez, B. K., & Catàlona, W. J. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)66705-3 · Cited by 81
Genetic and Environmental Factors in Prostate Cancer Genesis:Identifying High-Risk Cohorts
Ekman, P. (1999) · European Urology · doi:10.1159/000019910 · Cited by 78
The Etiopathogenesis of Prostatic Cancer with Special Reference to Environmental Factors
Bosland, M. C. (1988) · Advances in cancer research · doi:10.1016/s0065-230x(08)60220-1 · Cited by 74
Cellular and Molecular Pathology of Prostate Cancer Precursors
Foster, C. S., Bostwick, D. G., Bonkhoff, H., Damber, J., van der Kwast, T., Montironi, R., & Sakr, W. A. (2000) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/003655900750169284 · Cited by 74
Prostate Cancer Susceptibility Locus HPC1 in Utah High-Risk Pedigrees
Neuhausen, S. L., Farnham, J. M., Kort, E. N., Tavtigian, S. V., Skolnick, M. H., & Cannon‐Albright, L. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.13.2437 · Cited by 72
Association of codon 72 polymorphism of p53 with lower prostate cancer risk
Henner, W. D., Evans, A. J., Hough, K. M., Harris, E. L., Lowe, B. A., & Beer, T. M. (2001) · The Prostate · doi:10.1002/pros.10021 · Cited by 71
Hereditary prostate cancer
Bratt, O. (2000) · BJU International · doi:10.1046/j.1464-410x.2000.00457.x · Cited by 65
A Screening Study of Prostate Cancer in High Risk Families
McWhorter, W. P., Hernandez, A. D., Meikle, A. W., Terreros, D. A., Smith, J. A. J., Skolnick, M. H., Cannon‐Albright, L., & Eyre, H. J. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36733-2 · Cited by 69
Self-citation
Significance of Familial History of Prostate Cancer to Traditional Prognostic Variables, Genetic Biomarkers, and Recurrence after Radical Prostatectomy
Bauer, J. J., Srivastava, S. K., Connelly, R. R., Sesterhenn, I. A., Preston, D., McLeod, D. G., & Moul, J. W. (1998) · Urology · doi:10.1016/s0090-4295(98)00103-4 · Cited by 66
TNM classification of malignant tumors, fifth edition (1997)
Sobin, L. H., & Fleming, I. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971101)80:9 · Cited by 996
Family aggregation of cancer of the prostate in quebec: The tip of the iceberg
Ghadirian, P., Cadotte, M., Lacroix, A., & Perret, C. (1991) · The Prostate · doi:10.1002/pros.2990190105 · Cited by 62
Family History and the Risk of Prostatic Carcinoma in a High Risk Group of Urological Patients
Aprikian, A. G., Bazinet, M., PLANTE, M. K., Meshref, A. W., Trudel, C., Aronson, S., Nachabé, M., Péloquin, F., Dessureault, J., Narod, S. A., et al. (1995) · The Journal of Urology · doi:10.1097/00005392-199508000-00022 · Cited by 60
Sex hormone-induced nuclear DNA damage and lipid peroxidation in the dorsolaterel prostates of Noble rats
Ho, S., & Roy, D. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90370-0 · Cited by 55
The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9
McKiernan, J. M., Buttyan, R. E., Bander, N. H., TAILLE, A. D. L., STIFELMAN, M. D., Emanuel, E. R., Bagiella, E., Rubin, M. A., Katz, A. E., Olsson, C. A., et al. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990801)86:3 · Cited by 82
Restoration of functional defects in peripheral blood mononuclear cells isolated from cancer patients by thiol antioxidants alpha-lipoic acid and N-acetyl cysteine
Mantovani, G., Macci�, A., Melis, G. B., Mura, L., Massa, E., & Mudu, M. C. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000615)86:6 · Cited by 51
Familial study of prostate cancer in Jamaica
Glover, F. E., Coffey, D. S., Douglas, L. L., Russell, H. E., Cadigan, M., Tulloch, T., Wedderburn, K., Wan, R. L., Baker, T. D., & Walsh, P. C. (1998) · Urology · doi:10.1016/s0090-4295(98)00200-3 · Cited by 48
Molecular Genetics and Epidemiology of Prostate Carcinoma
Ruijter, E. T. G. (1999) · Endocrine Reviews · doi:10.1210/er.20.1.22 · Cited by 44
Epidemiology of prostate cancer: molecular and environmental clues
Pienta, K. J., Goodson, J. A., & Esper, P. S. (1996) · Urology · doi:10.1016/s0090-4295(96)00219-1 · Cited by 41
Estrogens and aspects of prostate disease
Prezioso, D., Denis, L., Klocker, H., Sciarra, A., Reis, M., Naber, K. G., Lobel, B., Pacík, D., & Griffiths, K. (2006) · International Journal of Urology · doi:10.1111/j.1442-2042.2006.01476.x · Cited by 35
Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families.
Matikainen, M. P., Schleutker, J., Mörsky, P. J., Kallioniemi, O., & Tammela, T. L. J. (1999) · PubMed · Cited by 34
A randomized double-blind study evaluating anandron® associated with orchiectomy in stage D prostate cancer
Namer, M., Toubol, J., Caty, A., Couette, J. E., Douchez, J., Kerbrat, P., & Droz, J. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90442-n · Cited by 34
Genetic epidemiology of prostate cancer.
Narod, S. (1999) · Biochimica et Biophysica Acta · doi:10.1016/s0304-419x(98)00030-4 · Cited by 22
Familial prostate cancer: the evidence and the Cancer Research Campaign/British Prostate Group (CRC/BPG) UK Familial Prostate Cancer Study.
Eeles, R., Dearnaley, D., Ardern-jones, A., Shearer, R., Easton, D., Ford, D., Edwards, S., & Dowe, A. (1997) · British Journal of Urology · doi:10.1111/j.1464-410x.1997.tb00795.x · Cited by 38
Familial and Hereditary Prostate Cancer by Definition in an Italian Surgical Series: Clinical Features and Outcome
Sacco, E., Prayer‐Galetti, T., Pinto, F., Ciaccia, M., Fracalanza, S., Betto, G., & Pagano, F. C. (2005) · European Urology · doi:10.1016/j.eururo.2005.01.016 · Cited by 30
Meta-analytic insights into factors influencing the repeatability of hormone levels in agricultural, ecological, and medical fields
Fanson, K. V., & Biro, P. A. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00006.2018 · Cited by 29
Progress in prostate cancer
Cannon-Albright, L., & Eeles, R. (1995) · Nature Genetics · doi:10.1038/ng0495-336 · Cited by 26
Environmental and genetic factors: a possible link with prostate cancer
Ekman, P., Pan, Y., Li, C., & Dich, J. (1997) · British Journal of Urology · doi:10.1111/j.1464-410x.1997.tb16919.x · Cited by 23
Hereditary aspects of prostate cancer.
McLellan, D. L., & Norman, R. W. (1995) · Europe PMC (PubMed Central) · Cited by 23
Familial prostate cancer studies in Utah.
Neuhausen, S., Skolnick, M., & Cannon-Albright, L. (1997) · British Journal of Urology · doi:10.1111/j.1464-410x.1997.tb00796.x · Cited by 25
Genetics and the common cancers
Houlston, R. S., & Peto, J. (1996) · Springer eBooks · doi:10.1007/978-1-4899-4501-3_13 · Cited by 20
The Prevention of Prostate Cancer
Griffiths, K., Prezioso, D., Turkes, A. O., & Denis, L. (2007) · Springer eBooks · doi:10.1007/978-3-540-40901-4_4 · Cited by 18
Androgens and the prostate
Frick, J., Jungwirth, A., & Rovan, E. (1998) · Springer eBooks · doi:10.1007/978-3-642-72185-4_9 · Cited by 18
Familial Prostate Cancer in Japan
Ohtake, N., Hatori, M., Yamanaka, H., Nakata, S., Sada, M., & Tsuji, T. (1998) · International Journal of Urology · doi:10.1111/j.1442-2042.1998.tb00262.x · Cited by 17
Associations between coronary heart disease, obesity and histological prostate cancer
Stamatiou, K. N., Alevizos, A., Mihas, K., Mariolis, A. D., Michalodimitrakis, E. N., & Sofras, F. (2006) · International Urology and Nephrology · doi:10.1007/s11255-006-9010-z · Cited by 16
Effect of combined testosterone and estradiol-17β treatment on the metabolism of E2 in the prostate and liver of noble rats
Lane, K. E., Ricci, M. J., & Ho, S. (1997) · The Prostate · doi:10.1002/(sici)1097-0045(19970301)30:4 · Cited by 14
[The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
Valéri, A., Berthon, P., Fournier, G., Buzzi, J.-C., Briollais, L., MERIA, P., Blanché, H., Bellanné‐Chantelot, C., Teillac, P., Démenais, F., et al. (1996) · PubMed · Cited by 13
Strategies for the management of recurrent and advanced urologic cancers. Quality of life
Herr, H. W. (1987) · Cancer · doi:10.1002/1097-0142(19870801)60:3+ · Cited by 15
Benign and Malignant Prostatic Neoplasms: Human Studies
Partin, A. W., & Coffey, D. S. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-571149-4.50020-9 · Cited by 12
Prostate cancer
Badalament, R. A., & Drago, J. R. (1991) · Disease-a-Month · doi:10.1016/0011-5029(91)90004-u · Cited by 12
Update in the management of prostate cancer
Raghavan, D., & Rogers, J. H. (1990) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1990.tb125270.x · Cited by 11
Hereditary Prostate Cancer
Isaacs, W. B., Xu, J., & Walsh, P. C. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-009-4_2 · Cited by 10
Hereditary Prostate Cancer
Damber, J. (1999) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365599950510012-1 · Cited by 9
Familial prostate cancer and its management
Eeles, R. A., & Cannon‐Albright, L. (1996) · Springer eBooks · doi:10.1007/978-1-4899-4501-3_22 · Cited by 8
Clinical and pathologic characteristics of familial prostate cancer in Asian population
Kim, M., Kim, J. K., Ye, C., Lee, H., Oh, J. J., Lee, S., Jeong, S. J., Lee, S.-C., Hong, S. K., & Byun, S. (2019) · The Prostate · doi:10.1002/pros.23917 · Cited by 7
The Clinical Genetics of Prostate Cancer
Kommu, S. S., Edwards, S. M., & Eeles, R. A. (2004) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-2-3-111 · Cited by 7
Relationship between HLA-DR Antigen and HLA-DRB1 Alleles and Prostate Cancer in Japanese Men
Azuma, H., Sada, M., Tsuji, T., Ueda, H., & Katsuoka, Y. (1999) · International Urology and Nephrology · doi:10.1023/a:1007126219791 · Cited by 6
AN ANALYSIS OF FAMILIAL PROSTATE CANCER
Nakata, S., Masuda, H., Satō, J., Shimizu, N., Suzuki, K., Imai, K., Yamanaka, H., Saito, K., Nakamura, T., Kato, N., et al. (1995) · The Japanese Journal of Urology · doi:10.5980/jpnjurol1989.86.1483 · Cited by 6
Human leukocyte antigen subtype analysis in patients with advanced adenocarcinoma of the prostate
Akdaş, A., Türkeri, L., Alican, Y., Şimşěk, F., & Akoğlu, T. (1994) · The Prostate · doi:10.1002/pros.2990240302 · Cited by 6
Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis
Simpson, C. L., Cropp, C. D., Wahlfors, T., George, A., Jones, M. S., Harper, U. L., Ponciano‐Jackson, D., Tammela, T. L. J., Schleutker, J., & Wilson, J. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.185 · Cited by 5
BIOLOGICAL AGGRESSIVENESS OF HEREDITARY PROSTATE CANCER
Bova, G. S., Partin, A. W., Isaacs, S. D., Carter, B. S., BEATY, T. L., Isaacs, W. B., & Walsh, P. C. (1998) · The Journal of Urology · doi:10.1097/00005392-199809010-00004 · Cited by 5
[Cancer of the prostate. 1. Epidemiology].
Auselo, N. M., Costa, P., Pellec, L. L., Louis, J., & Navratil, H. (1995) · PubMed · Cited by 5
Prostate cancer old problems and new approaches
Honn, K. V., Aref, A., Chen, Y. Q., Cher, M. L., rissman, J. D., Forman, J. D., Gao, X., Grignon, D. J., Hussain, M., Porter, A. T., et al. (1996) · Pathology & Oncology Research · doi:10.1007/bf02904824 · Cited by 5
Role of Genetic Polymorphisms in the Development and Prognosis of Sporadic and Familial Prostate Cancer
Reis, S. T., Viana, N. I., Leite, K. R. M., Erico, D., Antunes, A. A., Iscaife, A., Nesrallah, A., PASSEROTTI, C. C., Srougi, V., Pontes‐Júnior, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166380 · Cited by 4
Prostate cancer occurring in identical twins: A case report
Spaas, P., & Bagshaw, M. A. (1990) · The Prostate · doi:10.1002/pros.2990160305 · Cited by 4
Verletzungen und Erkrankungen der Prostata
Flüchter, S. H., Bichler, K.-H., Weigl, A., & Kalchthaler, M. (2004) · Springer eBooks · doi:10.1007/978-3-642-18568-7_12 · Cited by 3
Familial Aggregation of Prostate Cancer Management while Waiting for the Identification of Hereditary Prostate Cancer Genes
Damber, J. (2001) · European Urology · doi:10.1159/000052576 · Cited by 3
Familial Prostate Cancer
Kommu, S. S., & Eeles, R. A. (2005) · Springer eBooks · doi:10.1007/1-84628-015-x_2 · Cited by 2
Possible enhancement of prostate carcinogenesis by some chemoprevention agents
Bosland, M. C. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240501230 · Cited by 2
Prostate cancer old problems and new approaches
Honn, K. V., Aref, A., Chen, Y. Q., Cher, M. L., Crissman, J. D., Forman, J. D., Gao, X., Grignon, D. J., Hussain, M., Porter, A. T., et al. (1996) · Pathology & Oncology Research · doi:10.1007/bf02893960 · Cited by 2
Prostatakarzinom
Altwein, J. E., & Wirth, M. (1994) · Springer eBooks · doi:10.1007/978-3-662-22585-1_6 · Cited by 2
Familial Aspects of Prostate Cancer
Keetch, D. W., Rice, J. P., Suarez, B. K., & Catàlona, W. J. (1995) · The Journal of Urology · doi:10.1097/00005392-199512000-00038 · Cited by 2
Prostate Cancer Genetics
Kommu, S. S., Bishara, S., & Edwards, S. M. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2864-9_11 · Cited by 1
Genetic Epidemiology of Hereditary Prostate Cancer in Finland
Matikainen, M. P. (2001) · Tampere University Institutional Repository (Tampere University) · Cited by 1
Hereditary Predisposition and Prostate Cancer
Sacco, E., Prayer-Galetti, T., Pinto, F., Ciaccia, M., Fracalanza, S., Betto, G., & Pagano, F. C. (2005) · Urologia Journal · doi:10.1177/039156030507200201 · Cited by 1
Hereditary Aspects of Urologic Cancer
Naitoh, J., & Walzak, M. P. (1994) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(18)30505-2 · Cited by 1
The genetics of prostate cancer
Eeles, R. A. (1995) · Cancer biology and medicine · doi:10.1007/978-94-011-0677-1_4
GENETIC EPIDEMIOLOGY OF HEREDITARY PROSTATE CANCER IN FINLAND
Matikainen, M. P., Schleutker, J., Koivisto, P. A., Tammela, T. L. J., Xu, J., Isaacs, W. B., Smith, J. R., Carpten, J. D., Stephan, D. A., Wilson, J., et al. (1999) · The Journal of Urology · doi:10.1097/00005392-199904010-00220
Self-citation
Heterogeneity in Genetic Susceptibility to Prostate Cancer
Seppälä, E. H. (2006) · Tampere University Institutional Repository (Tampere University)
4 The genetics of prostate cancer
Eeles, R. A. (1995)

Authors: Wayne Meikle, A., Smith, J. A., & West, D. W.
Affiliations: University of Utah (US)
Venue: The Prostate
Publisher: Wiley
Published: 1985-01
Volume: 6
Issue: 2
Pages: 121-128
ISSN: 0270-4137 (ISSN-L)
1097-0045
DOI: 10.1002/pros.2990060202
OpenAlex: W1976692247
Cited by: 110
References: 49
Citations by year: 2019: 1 · 2018: 2 · 2016: 2 · 2015: 1 · 2012: 2
FWCI: 2.44
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 7870 d)
Locations: The Prostate (publishedVersion)
PubMed (publishedVersion)
Funders: National Cancer Institute (CA-25031)
National Center for Research Resources (RR-64)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords: prostate cancer, familial risk, plasma sex steroids, testosterone, dihydrotestosterone, sex hormone-binding globulin, free testosterone, androgen metabolism, Utah
MeSH terms: Adult, Aged, Humans, Male, Metabolic Clearance Rate, Middle Aged, Prostatic Neoplasms, Risk, Gonadal Steroid Hormones, Dihydrotestosterone, Testosterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Familial factors affecting prostatic cancer risk and plasma sex-steroid levels

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks